Cargando…
Calprotectin and SARS-CoV-2: A Brief-Report of the Current Literature
In late December 2019, a novel coronavirus (lately referred to as SARS-CoV-2) spread in the city of Wuhan, China, causing an outbreak of unusual viral pneumonia. In many people, the disease is mild and self-limiting, but in a considerable number of patients, the disease may present more severe or ev...
Autores principales: | Giuffrè, Mauro, Vetrugno, Luigi, Di Bella, Stefano, Moretti, Rita, Berretti, Debora, Crocè, Lory Saveria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392009/ https://www.ncbi.nlm.nih.gov/pubmed/34442092 http://dx.doi.org/10.3390/healthcare9080956 |
Ejemplares similares
-
COVID-19-Induced Thrombosis in Patients without Gastrointestinal Symptoms and Elevated Fecal Calprotectin: Hypothesis Regarding Mechanism of Intestinal Damage Associated with COVID-19
por: Giuffrè, Mauro, et al.
Publicado: (2020) -
Hepatitis C Virus-Related Central and Peripheral Nervous System Disorders
por: Moretti, Rita, et al.
Publicado: (2021) -
High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study
por: Zerbato, Verena, et al.
Publicado: (2021) -
Nonalcoholic Fatty Liver Disease and Altered Neuropsychological Functions in Patients with Subcortical Vascular Dementia
por: Moretti, Rita, et al.
Publicado: (2022) -
Comparison between hepatocellular carcinoma prognostic scores: A 10-year single-center experience and brief review of the current literature
por: Campigotto, Michele, et al.
Publicado: (2020)